Product
Supplier
Encyclopedia
Inquiry
Home > News > Market Flash > Kobayashi Pharmaceutical Health Products Contain Deadly Toxins, Official Confirmation of Health Crisis on September 18, 2024!

Kobayashi Pharmaceutical Health Products Contain Deadly Toxins, Official Confirmation of Health Crisis on September 18, 2024!

ECHEMI 2024-09-19

On September 18, 2024, according to Japanese media reports, the Japanese Ministry of Health, Labor and Welfare issued a statement in response to consumer health problems caused by health products containing monaskoji ingredients produced by Kobayashi Pharmaceutical Company, confirming that the "puberulic acid" detected in the problematic raw materials was the direct cause of health damage. Puberulinic acid is a natural compound produced by penicillium.


Kobayashi Pharmaceutical had previously reported to the Ministry of Health, Labour and Welfare that its plant in Osaka had found "puberulinic acid" in monaskoji raw material produced in September last year.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.